CareDx's CEO Sells 17K Shares
CareDx, a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions.
CareDx's CEO Sells 17K Shares
Overview
CareDx (NASDAQ:CDNA), a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions.
John Hanna, President and CEO of CareDx, disclosed the direct sale of 17,683 shares of common stock in an open-market transaction on June 15, as reported in the SEC Form 4 filing.
Details
Transaction value based on SEC Form 4 weighted average purchase price ($24.03); post-transaction value based on June 15 market close ($24.08).
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
